MAPT and tauopathy: Moreover, we chose to use tau oligomers isolated from wild-type mice, and not transgenic or tau overexpressing mouse models because the latter do not represent sporadic tauopathies (Narasimhan and Lee, 2017) and, more importantly, TBI-induced pathologies in normal brains.